Back
Arcturus Therapeutics Holdings, Inc. Stock Predictions
BlackRock's $91B Secret
Learn how to access Native Markets before Coinbase. Watch the free training.
Sell
19
ARCT
Arcturus Therapeutics Holdings, Inc.
Last Price:
$6.24
Seasonality Move:
-0.14%
7 Day Trial
ALL ACCESS PASS
$
7
Washington Wants Your Money. Here's How to Opt Out.
Learn how to become your own bank. Watch the free training.Arcturus Therapeutics Holdings, Inc. Stock Forecast
-
Over the next 52 weeks, Arcturus Therapeutics Holdings, Inc. has on average historically risen by 15% based on the past 12 years of stock performance.
-
Arcturus Therapeutics Holdings, Inc. has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Arcturus Therapeutics Holdings, Inc. Stock Undervalued?The current Arcturus Therapeutics Holdings, Inc. [ARCT] share price is $6.13. The Score for ARCT is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
ARCT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Arcturus Therapeutics Holdings, Inc. has on average historically risen by 15% based on the past 12 years of stock performance.
Arcturus Therapeutics Holdings, Inc. Stock Rating
Sell
19
Arcturus Therapeutics Holdings, Inc. (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings, Inc. overpriced?
-
Arcturus Therapeutics Holdings, Inc. has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Arcturus Therapeutics Holdings, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
24.17
52-Week Low:
5.85
Prediction Charts
Market Cap:
176.9M
Price in USD:
6.13
Volume:
635.1K
Beta:
2.50
Technical Analysis
SMA50:
8.28
SMA100:
13.49
SMA200:
12.93
52-Wk Change:
-63.88%
Stock Predictions
-
Is Arcturus Therapeutics Holdings, Inc. stock public?Yes, Arcturus Therapeutics Holdings, Inc. is a publicly traded company.
-
What is the Arcturus Therapeutics Holdings, Inc. stock quote today?The Arcturus Therapeutics Holdings, Inc. stock price is 6.13 USD today.
-
How to buy Arcturus Therapeutics Holdings, Inc. stock online?You can buy Arcturus Therapeutics Holdings, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-10 | 7.21 | 7.67 | 7.68 | 7.04 |
| Dec-11 | 7.65 | 7.52 | 7.76 | 7.47 |
| Dec-12 | 7.52 | 7.46 | 7.62 | 7.33 |
| Dec-15 | 7.37 | 7.25 | 7.54 | 7.12 |
| Dec-16 | 7.16 | 7.13 | 7.36 | 6.92 |
| Dec-17 | 7.09 | 6.52 | 7.21 | 6.49 |
| Dec-18 | 6.55 | 6.43 | 6.79 | 6.38 |
| Dec-19 | 6.44 | 6.53 | 6.63 | 6.40 |
| Dec-22 | 6.54 | 6.59 | 6.75 | 6.47 |
| Dec-24 | 6.45 | 6.50 | 6.56 | 6.40 |
| Dec-26 | 6.47 | 6.16 | 6.47 | 6.15 |
| Dec-29 | 6.13 | 6.16 | 6.29 | 6.07 |
| Dec-30 | 6.14 | 6.19 | 6.28 | 6.09 |
| Dec-31 | 6.10 | 6.13 | 6.17 | 6.02 |
Arcturus Therapeutics Holdings, Inc. Earnings
Arcturus Therapeutics Holdings, Inc. Earnings Report: Per Share Arcturus Therapeutics Holdings, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings, Inc. Forecast Revenue Growth
Arcturus Therapeutics Holdings, Inc. Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and an increase next year of $2.05 per share.
* Arcturus Therapeutics Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.